WCN24-1268 End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN)

IgAN is the most common primary glomerulonephritis worldwide with up to 40% of IgAN patients progressing to kidney failure within 20 years following diagnosis. Almost all patients with IgAN are expected to progress to kidney failure during their lifetime, regardless of age or estimated glomerular filtration rate (eGFR) at diagnosis. IgAN is characterized by race/ethnic predilection, heterogeneity in disease progression, and potential race/ethnic variations in treatment response. Previous studies have assessed disease progression in Asian and non-Hispanic white patients; however, there remains a lack of understanding of IgAN disease progression in Hispanic/Latino patients.